
AskRx Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 7.4/10
Best for: People who want a brand-name-only GLP-1 prescriber routing to NovoCare or LillyDirect.
AskRx is a solid telehealth option with balanced features and pricing.
No insurance needed · Vetted by our editors
AskRx is a US telehealth platform whose board-certified physicians exclusively prescribe FDA-approved, brand-name GLP-1 medications for weight loss - no compounded drugs. Offerings include the Wegovy pen and pill (semaglutide) and Zepbound (tirzepatide). AskRx does not dispense, compound, or sell medication; prescriptions are routed to manufacturer pharmacies such as NovoCare and LillyDirect at the patient's choice. A physician subscription runs $99-149/mo and medication is billed separately. LegitScript approved, HIPAA compliant, all 50 states. Subscription may be HSA/FSA eligible.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Vetted alternatives to AskRx
Sunlight
Best for: compounded GLP-1 with unlimited telehealth visits and free shipping
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
AskRx at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Wegovy pen & pill, Zepbound
- Starting price
- $199/mo
- Availability
- All 50 states
- FDA status
- No FDA warning letter on record
How we scored AskRx
Each dimension is scored algorithmically from AskRx’s real pricing, drugs offered, verification status, and disclosed inclusions — using the same six-dimension framework we apply to every provider.
Value25%
6.6/10At $199/mo, AskRx runs about 17% above the $170 median for GLP-1 providers.
Effectiveness25%
8.4/10AskRx offers both semaglutide and tirzepatide — the two GLP-1 molecules with the strongest published weight-loss trial outcomes. FDA-approved brand options are available alongside compounded versions.
User Experience15%
7.6/10Online intake and platform experience — app/portal-based; 8 platform features disclosed.
Trust & Safety15%
7.0/10Core details confirmed by our editors; no FDA warning letters on file (last checked 2026-06-06).
Accessibility10%
8.7/10AskRx treats patients in all 50 states. FSA/HSA cards are accepted.
Support10%
5.9/10AskRx provides standard clinician follow-up; no extended coaching or community program is disclosed.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this AskRx review
Last checked July 2026- Confirmed current pricing across 4 dose/plan tiers
- Confirmed availability in all 50 states
- Checked the FDA warning-letter database for enforcement actions
- Walked the public intake/checkout flow on the provider's site
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records — see the sources below. Editorial confidence in this data: medium.
What to expect when you sign up with AskRx
We walked AskRx’s public signup flow in July 2026 to document the process — the steps, pricing transparency, and what’s required — before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)
- 1Complete your profile by answering health questions and uploading records (about 5 minutes).
- 2Meet your physician via a messaging consultation with a board-certified obesity-medicine doctor.
- 3Get your medication dispensed through AskRx's own pharmacy and shipped.
- 4Ongoing monthly titration reviews adjust dosage over time.
- Care fee starts at $90/mo, shown before intake, and does not include medication cost.
- Medication is billed at the pharmacy's actual cost with no markup; both fees are itemized at checkout.
- No commitment required and cancel anytime, though no explicit refund policy is stated.
- Prescriptions typically ship within a few business days after being filled through their pharmacy.
- Video visits are available in select states as needed (not mandatory); patients may upload existing labs.
GLP-1 medications AskRx offers
Tap any medication to read our plain-English guide — how it works, dosing, side effects, and what the trials found.
Pricing
Prices re-verified
Ready to get started?
Plans and promotions change often — check AskRx's current pricing and active discounts before you decide.
What we like
- Prescribes only FDA-approved brand-name GLP-1s, no compounded drugs
- LegitScript approved and HIPAA compliant
- Board-certified physicians trained in obesity medicine
- Transparent dose-based pricing published on site
- Available in all 50 states
- Physician subscription may be HSA/FSA eligible
Watch-outs
- Cash-pay model; medication cost billed separately by the pharmacy
- Does not dispense medication itself, so fulfillment depends on third-party pharmacies
- No compounded lower-cost alternative offered
- Specific list of supported states is not published
AskRx in one line: a brand-name-only prescriber, not a pharmacy
AskRx is built for one specific kind of patient — the person who wants the real, FDA-approved brand drug and nothing else. Its board-certified physicians prescribe only Wegovy (the semaglutide pen and the newer pill) and Zepbound (tirzepatide). There is no compounded semaglutide here, no "research-grade" vials, no markups baked into a mystery bundle. If you've read the headlines about compounding-pharmacy quality concerns and decided you only trust the branded product from Novo Nordisk or Eli Lilly, AskRx is designed to be your front door to it. If you came looking for the cheapest possible GLP-1, this is not your provider — and AskRx is fairly upfront about that.
The unusual part: you pay AskRx for the doctor, and the pharmacy for the drug
Most telehealth weight-loss services quote you a single all-in monthly number that quietly folds the medication, the consult, and shipping together. AskRx deliberately splits the two apart, and understanding that split is the whole key to deciding whether it's worth it. Your AskRx subscription buys physician care only — the visit, the prescription, and ongoing oversight. The medication itself is billed separately, directly by the manufacturer's pharmacy, at the manufacturer's own self-pay price. In AskRx's own words, your subscription "covers physician care only — medication is paid separately, directly to the pharmacy."
The subscription is flat no matter which drug you're on, and it gets cheaper the longer you commit: a month-to-month plan sits at the top of the range, a three-month plan in the middle, and a six-month commitment brings it down to under a hundred dollars a month. Because it's a fee for medical services rather than for a product, the subscription may be HSA/FSA eligible — worth checking with your plan, since that can effectively shave the cost using pre-tax dollars.
What the medication actually costs
This is where you need to look past the subscription. The drug price is set by the manufacturer, not AskRx, and AskRx simply routes your prescription to NovoCare or LillyDirect (your choice). A new Wegovy pen patient starts around $199 a month on the introductory starter doses, then steps up to a higher all-doses rate once you're past the early titration. The Wegovy pill and Zepbound carry their own dose-based tiers, climbing as your dose climbs. For context, the category median across the providers we track is about $170 a month — so once you add the physician subscription on top of the branded drug price, AskRx lands on the premium end of the market, not the value end. That's the trade-off you're accepting in exchange for branded-only sourcing.
Who's writing the prescription, and can you trust it
On the oversight front AskRx checks the boxes that matter. The prescribers are board-certified physicians, described as trained in obesity medicine, and the platform is LegitScript approved and HIPAA compliant — LegitScript certification in particular is the credential we look for to separate legitimate telehealth from fly-by-night sellers. There are no FDA warning letters on file for AskRx in our records. Care is offered in all 50 states, which is broader than many competitors manage. Our editors verified the brand-only model and pricing structure directly from the company's site, and it's worth noting AskRx explicitly states it is not affiliated with the manufacturers or with TrumpRx — it's an independent prescriber, not a manufacturer storefront.
The honest drawbacks
The split-billing model is transparent, but it also means you'll juggle two charges every month, and the combined total — subscription plus branded medication — can run well past what a compounded program would cost. That's the central tension with AskRx: you're paying a premium for authenticity and physician access, and there is deliberately no lower-cost compounded fallback if your budget tightens.
- You pay two separate bills — AskRx for the doctor, the manufacturer pharmacy for the drug — so there's no single tidy monthly figure.
- Fulfillment depends entirely on third-party pharmacies (NovoCare, LillyDirect), so AskRx's own service can be great while a pharmacy backorder still stalls your refill.
- No compounded option means no escape valve if the branded price is more than you can sustain.
- The site lists "all 50 states" but doesn't publish a granular state-by-state confirmation, so verify your state at signup.
- Medication prices are set by the manufacturer and can change — AskRx's quoted drug figures are snapshots, not guarantees.
Who should pick AskRx — and who should walk away
Choose AskRx if you specifically want genuine Wegovy or Zepbound, you value a clear line between what you pay the doctor and what you pay the pharmacy, and you can either tap insurance/HSA dollars or comfortably afford manufacturer self-pay pricing. The unbundled structure is genuinely a feature for the right person — you can see exactly what the medical care costs versus the drug, with no hidden product markup. Walk away if price is your deciding factor, if you were hoping for an affordable compounded semaglutide, or if you want a provider that ships the medication to you directly as one package.
Bottom line
AskRx is a clean, credible, brand-name-only prescriber that does exactly one thing and is honest about it: it connects you to a real physician who writes you a real prescription for FDA-approved Wegovy or Zepbound, then steps out of the way and lets the manufacturer's pharmacy fill it. The unbundled pricing is refreshingly transparent, the credentials are solid, and the coverage is nationwide. Just go in clear-eyed that this is a premium, no-compounding route — you're paying for authenticity and oversight, not for the lowest sticker price. See how that stacks up in our scoring methodology before you commit.
Shopping around? RNK Health ($197/month) and Care Bare Rx ($199/month) are the nearest alternatives to AskRx in our rankings.
The Bottom Line
AskRx is a solid telehealth option with balanced features and pricing.
Ready to start with AskRx?
Starting at $199/month. See current pricing and start your free consultation.
AskRx might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
- If the lowest possible monthly price is your top priority, consider Sesame Care (from $59/mo).
- If you want built-in coaching and behavior-change support, consider Found.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this AskRx review:
Sources & methodology — as of July 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See AskRx's current pricing
Plans start at $199/month. Start your free consultation to check eligibility and today's price.